|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF ARRAY BIOPHARMA INC., AS AND FOR THE YEAR ENDED
JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-01-1999
<PERIOD-END> JUN-30-2000
<CASH> 3,846,407
<SECURITIES> 1,937,099
<RECEIVABLES> 885,522
<ALLOWANCES> 0
<INVENTORY> 1,557,376
<CURRENT-ASSETS> 8,548,093
<PP&E> 8,406,154
<DEPRECIATION> 1,495,397
<TOTAL-ASSETS> 15,823,192
<CURRENT-LIABILITIES> 6,338,200
<BONDS> 0
0
9,835
<COMMON> 3,370
<OTHER-SE> 6,639,364
<TOTAL-LIABILITY-AND-EQUITY> 15,823,192
<SALES> 0
<TOTAL-REVENUES> 6,773,634
<CGS> 4,402,269
<TOTAL-COSTS> 4,402,269
<OTHER-EXPENSES> 4,643,852
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 384,378
<INCOME-PRETAX> (4,730,418)
<INCOME-TAX> 0
<INCOME-CONTINUING> (4,730,418)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,730,418)
<EPS-BASIC> (1.54)
<EPS-DILUTED> (1.54)
</TABLE>
|
|